Breaking News

Rentschler Biopharma’s New Production Line in Milford, MA Becomes Fully Operational

The multi-product facility is focused primarily on commercial production of highly complex molecules.

Author Image

By: Charlie Sternberg

Associate Editor

Rentschler Biopharma SE’s new production line, formerly known as the Rentschler Biopharma Manufacturing Center (RBMC), in Milford, MA in the U.S. is now fully operational. The new production line is the largest investment in Rentschler Biopharma’s more than 150-year history. The CDMO already has a major project underway at the new line, with several additional projects in the pipeline, and continues to welcome new projects and clients. The multi-product facility, which doubles Rentschler...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters